Skip to content

Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia

Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03711227
Enrollment
185
Registered
2018-10-18
Start date
2018-07-17
Completion date
2019-08-01
Last updated
2024-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Keywords

Serial Procalcitonin, Admitted Pneumonia, qSOFA, Sepsis

Brief summary

Procalcitonin levels checked initially and at 24 hours will correlate with disease severity, morbidity, and mortality. Patients who have a higher procalcitonin level initially and at 24 hours will likely have higher qSOFA scores, longer lengths of stay, longer duration of antibiotics and higher 30 day mortality rates.

Detailed description

A procalcitonin order bundle will be created for admitted patients with pneumonia. This prepopulated bundle includes an initial and 24 hour procalcitonin level, much like the current initial and 4 hour lactate orders are set-up. These patients will receive treatment for their pneumonia as is deemed appropriate by their care teams, both in the Emergency Department and while an inpatient. Then, after discharge, the 30 day mortality, length of stay, choice of antibiotic therapy, and qSOFA score (which will be retroactively calculated) will be compared to the patient's initial and 24 hour procalcitonin level.

Interventions

DIAGNOSTIC_TESTProcalcitonin lab test

A procalcitonin order bundle will be created for admitted patients with pneumonia. This prepopulated bundle includes an initial and 24 hour procalcitonin level.

Sponsors

Michigan State University
CollaboratorOTHER
Corewell Health South
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients seen at Lakeland St. Joseph and Niles Hospitals in the emergency department and who are then subsequently admitted with pneumonia at Lakeland St. Joseph and Niles Hospitals

Exclusion criteria

* Any patients not admitted with pneumonia, any patients who are admitted with another primary diagnosis other than pneumonia, any patients who do not have an initial or 24 hour procalcitonin level result, and any patients less than 18 years old

Design outcomes

Primary

MeasureTime frameDescription
Change in Procalcitonin levelMeasured at baseline and at 24 hoursChange in procalcitonin level in the blood serum

Secondary

MeasureTime frameDescription
qSOFA scorebaseline and at 24 hoursqSOFA score is based on blow blood pressure, high respiratory rate, and altered mental status
Length of stayan average of 30 daysLength of stay in days, total stay from admission until discharge
Duration of antibioticsan average of 30 daysAntibiotic treatment length in days
30 Day Mortality30 daysNumber of patients who expire vs those alive at 30 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026